On Invalid Date, Enlivex Therapeutics (NASDAQ: ENLV) reported Q3 2023 earnings per share (EPS) of -$0.32, up 3.23% year over year. Total Enlivex Therapeutics earnings for the quarter were -$5.96 million. In the same quarter last year, Enlivex Therapeutics's earnings per share (EPS) was -$0.31.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.